Tag: Alexion Pharmaceuticals

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Alexion Pharmaceuticals

Here's Why ClearBridge Investments Disposed its Alexion Pharmaceuticals (ALXN) Stake

Added to Collection on: 2021-06-16 16:41:15

Tags for this article:

Finance
Life Sciences
Alternative investment management companies
Alexion Pharmaceuticals
AstraZeneca
Biotechnology
Hedge fund
Russell 1000 Index
Russell 1000 Growth Price Return USD

Click the tags to see associated articles and topics

View Article Details
Roche's neuromyelitis optica drug Enspryng wins EU approval

Added to Collection on: 2021-06-28 06:22:30

Tags for this article:

Orphan drugs
Drugs
Health care
Clinical medicine
Immunosuppressants
Central nervous system disorders
Myelitis
Antineoplastic drugs
Alexion Pharmaceuticals
Devic
Eculizumab
Inebilizumab
ROG.S
Roche

Click the tags to see associated articles and topics

View Article Details
Rare diseases: Tackling unmet needs and evolving the orphan drug environment

Added to Collection on: 2021-07-05 08:03:45

Tags for this article:

Life Sciences
Health sciences
Health
Rare disease
European Organisation for Rare Diseases
Alexion Pharmaceuticals
Orphan drug
Pharmaceutical industry
Genetic Alliance UK

Click the tags to see associated articles and topics

View Article Details
AstraZeneca collaboration and investment agreement with Cellectis

Added to Collection on: 2023-11-01 19:22:30

Tags for this article:

Cellectis
Medical research
AstraZeneca
André Choulika
Biotechnology
Oxford–AstraZeneca COVID-19 vaccine
Alexion Pharmaceuticals
Gene therapy
Pharmaceutical industry in India
AstraZeneca plc

Click the tags to see associated articles and topics

View Article Details
Neuromyelitis Optica Spectrum Disorder Pipeline Analysis, 2023 Updates - Digital Journal

Added to Collection on: 2023-12-09 03:45:11

Tags for this article:

Autoimmune diseases
Inebilizumab
Neuromyelitis optica spectrum disorder
Optic neuritis
Edgley Optica
Aquaporin-4
Devic
NMO
Alexion Pharmaceuticals

Click the tags to see associated articles and topics

View Article Details
FDA Approves AstraZeneca's Ultomiris for NMOSD - BioPharm International

Added to Collection on: 2024-03-28 19:27:53

Tags for this article:

Alexion Pharmaceuticals
AstraZeneca
Neuromyelitis optica spectrum disorder
Oxford–AstraZeneca COVID-19 vaccine

Click the tags to see associated articles and topics

View Article Details
Generalized Myasthenia Gravis Market Forecast 2032: FDA, EMA, PDMA Approvals, Clinical ...

Added to Collection on: 2024-05-08 18:43:07

Tags for this article:

Orphan drugs
Autoimmune diseases
GMG
Myasthenia gravis
Rozanolixizumab
Gravis
Myasthenia
Ptosis
Celgene Corporation
Janssen Research & Development LLC
Vertex Pharmaceuticals Incorporated
Alexion Pharmaceuticals
argenx
UCB Pharma
HOFFMANN - LA ROCHE

Click the tags to see associated articles and topics

View Article Details
Roche's PIASKY Approval for Paroxysmal Nocturnal Hemoglobinuria Treatment Will Give ...

Added to Collection on: 2024-09-02 21:31:58

Tags for this article:

Orphan drugs
Immunosuppressants
Monoclonal antibodies
Hematology
Pegcetacoplan
Crovalimab
Eculizumab
Iptacopan
Alexion Pharmaceuticals
Paroxysmal nocturnal hemoglobinuria
Ravulizumab
Danicopan
United States
AstraZeneca

Click the tags to see associated articles and topics

View Article Details
First targeted treatment on the PBS for rare, unpredictable and debilitating autoimmune ...

Added to Collection on: 2025-03-31 19:03:58

Tags for this article:

Monoclonal antibodies
Orphan drugs
Rare diseases
Autoimmune diseases
Blood disorders
Eculizumab
Neuromyelitis optica spectrum disorder
Multiple sclerosis
Meningococcal disease
Atypical hemolytic uremic syndrome
Alexion Pharmaceuticals
Myelin oligodendrocyte glycoprotein
Australia
Alexion Pharmaceuticals Australasia Pty Ltd.

Click the tags to see associated articles and topics

View Article Details
Atypical Hemolytic Uremic Syndrome Pipeline 2025: Detailed Clinical Trials and FDA ...

Added to Collection on: 2025-09-03 22:59:22

Tags for this article:

Blood disorders
Monoclonal antibodies
Acquired hemolytic anemia
Alexion Pharmaceuticals
AstraZeneca
Atypical hemolytic uremic syndrome
Ahus
Eculizumab
Hemolytic–uremic syndrome
Crovalimab
Complement factor I
Hemolysis

Click the tags to see associated articles and topics

View Article Details
Book a Demo